PI-200 and PI-201, new platelet aggregation inhibitors produced by Streptomyces sp. A7498. Taxonomy, fermentation, isolation, physico-chemical properties, structure determination and biological properties. 1992

Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.

Two new platelet aggregation inhibitors, PI-200 and PI-201 were isolated from the fermentation broth of Streptomyces sp. A7498. PI-200 and PI-201 inhibited ADP-induced aggregation of rabbit platelets with an IC50 of 3.8 x 10(-4) M and 7.1 x 10(-4) M, respectively.

UI MeSH Term Description Entries
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
July 1989, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
December 1995, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
July 1994, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
May 1990, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
October 1994, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
March 1998, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
March 1999, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
December 1998, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
November 1994, The Journal of antibiotics,
Y Kishimura, and A Kawashima, and T Kagamizono, and M Yamagishi, and K Matsumoto, and Y Kawashima, and K Hanada
August 2000, The Journal of antibiotics,
Copied contents to your clipboard!